Navigation Links
Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting
Date:7/14/2008

in diet induced and genetically obese animal models. The poster described the inhibition of PTP-1B by MSI-1436 as fully reversible and characterized by a classic noncompetitive, dose-dependent mechanism which exhibited greatest potency for the full-length form of the enzyme. Cellular studies demonstrating that phosphatase inhibition by MSI-1436 in the presence of insulin pretreatment provided further support for the inhibition of PTP-1B and a greater understanding of the role of enhanced insulin signaling associated with weight loss and glucose control observed during treatment in preclinical models of obesity and diabetes with MSI-1436.

To date, MSI-1436 has been shown to have few adverse events and to be well-tolerated in the over 50 subjects who participated in the Phase 1 clinical program of MSI-1436. Genaera plans to conduct an ascending multiple-dose study later this year.

About Trodusquemine (MSI-1436)

Trodusquemine is a centrally and peripherally-acting appetite suppressant and the first highly selective inhibitor of protein tyrosine phosphatase 1B (PTP-1B). PTP-1B is central to controlling the function of both the leptin and insulin pathways. By inhibiting PTP-1B, MSI-1436 is expected to decrease appetite and normalize blood sugar. Trodusquemine has produced consistent, sustainable weight loss in a variety of animal models and appears to overcome metabolic readjustment, which often limits sustained weight loss during caloric restriction. In addition, trodusquemine has shown the ability to reverse co-morbidities associated with obesity such as abnormal glucose metabolism and cholesterol elevation.

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a phase
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
2. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
3. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
4. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
5. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
6. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
7. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
8. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
9. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
10. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
11. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... RICHMOND, Calif. , July 29, 2015 ... that the company will release its second quarter 2015 ... 5, 2015. The press release will be followed by ... be open to the public via telephone and webcast. ... quarter,s financial results and discuss other business matters. ...
(Date:7/29/2015)... July 29, 2015 The U.S. Food and ... called the ReShape Integrated Dual Balloon System, that may ... for people with obesity and one or more obesity-related ... Bariatric Surgery (ASMBS), the nation,s largest organization for bariatric ... after careful review the FDA has approved this new ...
(Date:7/29/2015)... July 29, 2015 According to ... by Product, Diagnostic (PSG, Pulse Oximeter), Therapeutic [CPAP, APAP, ... Device)], End User (Home Care Settings, Hospitals) - Analysis ... report studies the global Sleep Apnea Devices Market for ... is expected to reach $5.3 Billion by 2020 from ...
Breaking Medicine Technology:Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3Sleep Apnea Devices Market Worth $5.3 Billion by 2020 2Sleep Apnea Devices Market Worth $5.3 Billion by 2020 3Sleep Apnea Devices Market Worth $5.3 Billion by 2020 4
... 2011 Informex , the leading meeting place for ... of applications, today announced projections that 2011 will be a ... the brand,s flagship event, InformexUSA (February 7-10, Charlotte, NC). Exhibitor ... new exhibitors joining the show. On the registrations side, year ...
... 2011 Reportlinker.com announces that a new ... catalogue: Dental Implants and ... and Market Forecasts to 2016 ... Implants and Biomaterials - Global Pipeline Analysis, ...
Cached Medicine Technology:InformexUSA 2011 Projects Record Attendance 2InformexUSA 2011 Projects Record Attendance 3Reportlinker Adds Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3
(Date:7/29/2015)... ... 29, 2015 , ... Potomac Pilates, an elite Washington, D.C. metro area-based Pilates ... Reformer ® by Potomac Pilates. On Thursday, July 30, Potomac Pilates will unveil ... by Potomac Pilates will continue to offer the same classes and personal experiences their ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Parents, educators and service providers of children living with autism will converge upon ... the growing demographic. , The National Autism Conference will be held Aug. ...
(Date:7/29/2015)... ... July 29, 2015 , ... The NCCA re-accredited ... period, expiring November 30, 2019, during its recent meeting. , The Commission received ... the program’s compliance with the NCCA’s Standards for the Accreditation of Certification Programs. ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... According ... patients suffering from drug or alcohol addiction and mental health disorders. Acu-detox may begin ... of treating patients recovering from drug and alcohol addiction. Although acupuncture is not a ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Orthopedic surgeons ... now offer the Rotation Medical Rotator Cuff System, a new implant to treat a ... is designed to foster natural regeneration of additional tendon tissue, which could allow for ...
Breaking Medicine News(10 mins):Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3
... over same period in Fiscal 2008 -, ... unless otherwise noted),BELLEVILLE, ON, Feb. 6 /PRNewswire-FirstCall/ - ... technology-driven Canadian biopharmaceutical company, today announced financial results ... year, ending December 31, 2008. , "We have ...
... the first to make a connection between a rare, hereditary ... The study results point to possible therapeutic targets for smoking-related ... is lost in Werner,s syndrome is decreased in smokers with ... wounds. The findings appear in the Feb. 6 issue of ...
... - WuXi PharmaTech (Cayman) Inc.,(NYSE: WX ), ... outsourcing company with operations in China and the,United States, ... Zhao to,the WuXi PharmaTech Board of Directors. , ... Dr. Ge Li, WuXi,s Chairman ...
... Stater Bros. has raised over $1.9 million in the ... Bros. is once again partnering with the American Heart ... Heart Month, to help fight heart disease and stroke. ... "Have A Heart, Save A Heart" campaign to raise ...
... Bite Cases Doubled in 2008 , ... Baltimore, MD (Vocus) February 5, ... cases handled by its Emergency Response Center in 2008. This has experts ... possibility that travelers might contract the deadly rabies virus from rabid wild ...
... mark 1st official measure of unemployment rate facing Americans ... Department of Labor will, for the first time, release ... Friday, Feb. 6. This information will assist the ... Americans with disabilities. Although it is widely believed ...
Cached Medicine News:Health News:Bioniche Reports Fiscal 2009 Second Quarter 2Health News:Bioniche Reports Fiscal 2009 Second Quarter 3Health News:Bioniche Reports Fiscal 2009 Second Quarter 4Health News:Bioniche Reports Fiscal 2009 Second Quarter 5Health News:Bioniche Reports Fiscal 2009 Second Quarter 6Health News:Bioniche Reports Fiscal 2009 Second Quarter 7Health News:Bioniche Reports Fiscal 2009 Second Quarter 8Health News:Bioniche Reports Fiscal 2009 Second Quarter 9Health News:Effects of smoking linked to accelerated aging protein 2Health News:WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board 2Health News:WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board 3Health News:Stater Bros. Campaigns to Fight Heart Disease and Stroke... At All Stater Bros. Supermarket Locations 2Health News:MEDEX Global Group Cautions: Beware of Rabies When Abroad 2Health News:U.S. Labor Department to begin new monthly data series on people with disabilities from Current Population Survey on Feb. 6 2
... This lightweight orthosis is designed to ... thumb while holding the hand in a ... formulated orthopedic grade thermoplastic whose unique characteristics ... The orthosis provides rigid cast-like immobilization of ...
... wrist orthotic designed to limit the extension and flexion ... , ,Indications: , Wrist reconstruction , ... , Coles fracture - distal radius , ... , ORIF - Open reduction and internal ...
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility...
Provides wrist stability with moderate motion restriction, making it ideal for the workplace...
Medicine Products: